FindTrial
Sign In

Reinfection with SARS-COV-2 and associated factors

Risk of COVID-19 re-infection and its predictors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029438
Enrollment
600
Registered
2020-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Christian Medical College Vellore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Residents of the study area

Exclusion criteria

Exclusion criteria: Acute febrile illness compatible with COVID19 at recruitment

Design outcomes

Primary

MeasureTime frame
PCR confirmed SARS-COV-2 infectionTimepoint: 104 weekly samples for asymptomatic infection and adhoc samples when presenting with clinical illness compatible with COVID-19—

Secondary

MeasureTime frame
cross-reactive T cells to non-SARS-CoV-2 human Coronaviruses (hCoV)Timepoint: Baseline at recruitment;Memory B Cell AssaysTimepoint: Baseline, At diagnosis of COVID-19 (D0), 2 weeks, 4 weeks, 3 months, 6 months and 12 months following diagnosis;SARS-COV-2 specific T Cell responsesTimepoint: Baseline, At diagnosis of covid-19 (D0), 2 weeks, 4 weeks, 3 months, 6 months, 12 months following diagnosis—

Countries

India

Contacts

Public ContactJacob John

Christian Medical College Vellore

jebu@cmcvellore.ac.in9442631628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026